284 related articles for article (PubMed ID: 12872499)
1. Immunocytological and mineralogical study of bronchoalveolar lavage in a group of subjects exposed to asbestos.
Brunetti G; Delmastro M; Fonte R; Moscato G; Bossi A; Baiardi P; Massola A; Meloni F
G Ital Med Lav Ergon; 2003; 25(2):152-60. PubMed ID: 12872499
[TBL] [Abstract][Full Text] [Related]
2. Bronchoalveolar lavage and clearance of 99m-Tc-DTPA in asbestos workers without evidence of asbestosis.
Gellert AR; Langford JA; Uthayakumar S; Rudd RM
Br J Dis Chest; 1985 Jul; 79(3):251-7. PubMed ID: 3893510
[TBL] [Abstract][Full Text] [Related]
3. [Assessment of asbestos exposure via mineralogical analysis of bronchoalveolar lavage fluid].
Romeo R; Scancarello G; Cassano P; Cioni F; Bacaloni A; Sartorelli P
Med Lav; 2004; 95(1):17-31. PubMed ID: 15112744
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast mitogens in bronchoalveolar lavage (BAL) fluid from asbestos-exposed subjects with and without clinical evidence of asbestosis: no evidence for the role of PDGF, TNF-alpha, IGF-1, or IL-1 beta.
Mutsaers SE; Harrison NK; McAnulty RJ; Liao JY; Laurent GJ; Musk AW
J Pathol; 1998 Jun; 185(2):199-203. PubMed ID: 9713348
[TBL] [Abstract][Full Text] [Related]
5. [Estimate of the previous exposure to asbestos through mineralogical examination of the bronchoalveolar lavage (BAL) fluid in a population working in a sugar industry].
Sartorelli P; Romeo R; Sisinni AG; Paolucci V; Peccetti V; Sallese D; Scancarello G
G Ital Med Lav Ergon; 2007; 29(3 Suppl):644-6. PubMed ID: 18411447
[TBL] [Abstract][Full Text] [Related]
6. [Significance of bronchoalveolar lavage in demonstrating previous exposure to asbestos].
Rivolta G; Prandi E; Sogliani M; Picchi O
Med Lav; 2001; 92(3):166-72. PubMed ID: 11515149
[TBL] [Abstract][Full Text] [Related]
7. Measurement of asbestos fibre concentrations in fluid of repeated bro-choalveolar lavages of exposed workers.
Sartorelli P; Romeo R; Scancarello G; Montomoli L; Muzzupappa C; Barabesi L
Ann Occup Hyg; 2007 Jul; 51(5):495-500. PubMed ID: 17456581
[TBL] [Abstract][Full Text] [Related]
8. [The clinical utility of asbestos body counts in bronchoalveolar lavage fluid].
Takabe K; Tsukada Y; Shimizu T; Takagiwa J; Hirayama M; Nakayama M; Miura H; Akabane H; Takayama S; Aida S
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Nov; 35(11):1196-204. PubMed ID: 9493446
[TBL] [Abstract][Full Text] [Related]
9. [Expression of adhesion molecules LFA-1 (CD11a and ICAM-1 (CD54) on lymphocytes and chemokines IL-8 and MCP-1 concentrations in bronchoalveolar lavage of patients with asthma or chronic obstructive pulmonary disease].
Jahnz-Rózyk K; Chciałowski A; Pirozyńska E; Rogalewska A
Pol Merkur Lekarski; 2000 Oct; 9(52):649-52. PubMed ID: 11144049
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of MCP-1, MIP-alpha and MIP-1 beta in the bronchoalveolar lavage (BAL) fluid of patients with mustard gas-induced pulmonary fibrosis.
Emad A; Emad V
Toxicology; 2007 Oct; 240(1-2):60-9. PubMed ID: 17720292
[TBL] [Abstract][Full Text] [Related]
11. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.
Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Skibova J; Striz I
Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539
[TBL] [Abstract][Full Text] [Related]
12. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
Schildge J; Klar B; Hardung-Backes M
Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
[TBL] [Abstract][Full Text] [Related]
13. Correlation of bronchoalveolar lavage and clinical and functional findings in asbestosis.
Xaubet A; Rodriguez-Roisín R; Bombí JA; Marín A; Roca J; Agustí-Vidal A
Am Rev Respir Dis; 1986 May; 133(5):848-54. PubMed ID: 3706896
[TBL] [Abstract][Full Text] [Related]
14. [Simple evaluation of numbers of asbestos bodies in bronchoalveolar lavage fluid under light microscopy: analysis of 35 pulmonary nodular lesions].
Kawahara K; Kawasumi H; Nagano T; Sasada S; Okamoto N
Rinsho Byori; 2008 Apr; 56(4):290-6. PubMed ID: 18516963
[TBL] [Abstract][Full Text] [Related]
15. [The content of asbestos bodies in the bronchoalveolar fluid as a parameter of an increased pulmonary asbestos load].
Teschler H; Hoheisel G; Fischer M; Müller KM; Konietzko N; Costabel U
Dtsch Med Wochenschr; 1993 Dec; 118(48):1749-54. PubMed ID: 8253027
[TBL] [Abstract][Full Text] [Related]
16. [Tumor necrosis factor alpha in bronchoalveolar lavage fluid and its production by alveolar macrophages with asbestos exposure].
Tokuyama T; Yoneda T; Tsukaguchi K; Yoshikawa M; Fu A; Tomoda K; Nakaya M; Narita N; Tamura M; Miyazaki R
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Mar; 32(3):205-10. PubMed ID: 8189639
[TBL] [Abstract][Full Text] [Related]
17. Health effects of acute exposure to air pollution. Part I: Healthy and asthmatic subjects exposed to diesel exhaust.
Holgate ST; Sandström T; Frew AJ; Stenfors N; Nördenhall C; Salvi S; Blomberg A; Helleday R; Söderberg M
Res Rep Health Eff Inst; 2003 Dec; (112):1-30; discussion 51-67. PubMed ID: 14738208
[TBL] [Abstract][Full Text] [Related]
18. [Cytoimmunological changes in the bronchoalveolar lavage in asbestos exposure patients].
Gil K
Folia Med Cracov; 2006; 47(1-4):21-36. PubMed ID: 18038610
[TBL] [Abstract][Full Text] [Related]
19. [Markers of fibrogenesis in bronchoalveolar lavage and in serum of workers exposed to asbestos].
Salberini I; Rivolta G; Todaro A; Forni A; Annoni G; Chiappino G
Med Lav; 1991; 82(3):238-47. PubMed ID: 1795668
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of CD30 as a marker for th2 lymphocytes in bronchoalveolar lavage in interstitial lung diseases.
Petkova D; Xaubet A; Picado C; Filella X; Agusti C; Luburich P; Rodriguez-Roisin R
Respir Med; 2000 Apr; 94(4):345-9. PubMed ID: 10845432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
